Charles River Laboratories to Present at Barclays Global Healthcare Conference
Charles River Laboratories (NYSE: CRL) has announced its upcoming presentation at the Barclays 27th Annual Global Healthcare Conference scheduled for Wednesday, March 12th, at 9:30 a.m. ET.
During the presentation, management will provide insights into the company's:
- Strategic focus
- Business developments
- Recent trends
Investors and interested parties can access a live webcast of the presentation through the Investor Relations section at ir.criver.com. A replay will be available on the same platform for a minimum of two weeks following the presentation.
Charles River Laboratories (NYSE: CRL) ha annunciato la sua prossima presentazione alla 27ª Conferenza Annuale Globale sulla Salute di Barclays, programmata per mercoledì 12 marzo, alle 9:30 ET.
Durante la presentazione, la direzione fornirà approfondimenti sul:
- Focus strategico
- Sviluppi aziendali
- Tendenze recenti
Investitori e parti interessate possono accedere a un webcast dal vivo della presentazione attraverso la sezione Relazioni con gli Investitori su ir.criver.com. Una registrazione sarà disponibile sulla stessa piattaforma per un minimo di due settimane dopo la presentazione.
Charles River Laboratories (NYSE: CRL) ha anunciado su próxima presentación en la 27ª Conferencia Anual Global de Salud de Barclays, programada para el miércoles 12 de marzo a las 9:30 a.m. ET.
Durante la presentación, la dirección proporcionará información sobre:
- Enfoque estratégico
- Desarrollos empresariales
- Tendencias recientes
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Relaciones con Inversores en ir.criver.com. Una repetición estará disponible en la misma plataforma durante un mínimo de dos semanas después de la presentación.
찰스 리버 연구소 (NYSE: CRL)는 바클레이스 제27회 연례 글로벌 헬스케어 컨퍼런스에서의 발표를 3월 12일 수요일 오전 9시 30분 ET에 예정하고 있음을 발표했습니다.
발표 동안 경영진은 회사의:
- 전략적 초점
- 사업 개발
- 최근 동향
투자자 및 관심 있는 당사자는 ir.criver.com의 투자자 관계 섹션을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 발표 후 최소 2주 동안 동일한 플랫폼에서 재생이 가능할 것입니다.
Charles River Laboratories (NYSE: CRL) a annoncé sa prochaine présentation lors de la 27ème Conférence Annuelle Mondiale sur la Santé de Barclays, prévue pour le mercredi 12 mars à 9h30 ET.
Lors de cette présentation, la direction fournira des informations sur :
- Focus stratégique
- Développements commerciaux
- Tendances récentes
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Relations Investisseurs sur ir.criver.com. Un enregistrement sera disponible sur la même plateforme pendant un minimum de deux semaines après la présentation.
Charles River Laboratories (NYSE: CRL) hat seine bevorstehende Präsentation auf der 27. jährlichen globalen Gesundheitskonferenz von Barclays angekündigt, die für Mittwoch, den 12. März, um 9:30 Uhr ET geplant ist.
Während der Präsentation wird das Management Einblicke in:
- Strategische Ausrichtung
- Geschäftsentwicklungen
- Aktuelle Trends
Investoren und interessierte Parteien können über den Bereich Investor Relations auf ir.criver.com auf ein Live-Webcast der Präsentation zugreifen. Eine Wiederholung wird auf derselben Plattform für mindestens zwei Wochen nach der Präsentation verfügbar sein.
- None.
- None.
A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311462644/en/
Investor Relations Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When is Charles River Laboratories (CRL) presenting at the Barclays Healthcare Conference?
How can investors watch Charles River Laboratories' (CRL) Barclays conference presentation?
What topics will CRL management cover in their Barclays conference presentation?
How long will the CRL Barclays conference presentation replay be available?
